As of May 24
| -0.0106 / -2.51%|
The 2 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 3.25, with a high estimate of 4.50 and a low estimate of 2.00. The median estimate represents a +689.22% increase from the last price of 0.41.
The current consensus among 2 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.